14 December 2018: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce its interim results for the six months ended 30 September 2018.
To log on to view the webcast of the analyst presentation please click here…
To view the Interim Results Presentation slide deck please click here…